Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 22
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03373435 | Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia | ||
| NCT02771574 | Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia | ||
| NCT02664558 | A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) | ||
| NCT05229991 | Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection | ||
| NCT04343976 | Pegylated Interferon Lambda Treatment for COVID-19 | ||
| NCT00945880 | Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive | ||
| NCT02700529 | Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA) | ||
| NCT02430194 | Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2) | ||
| NCT02430181 | Lonafarnib With and Without Ritonavir in HDV (LOWR-1) | ||
| NCT02765802 | A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection | ||
| NCT05070364 | Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV | ||
| NCT04652479 | Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia | ||
| NCT02527707 | Titrating-Dose of Lonafarnib in Combination With Ritonavir | ||
| NCT04388709 | Interferon Lambda Therapy for COVID-19 | ||
| NCT01316185 | Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) | ||
| NCT03895528 | Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy | ||
| NCT04727424 | Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms | ||
| NCT03719313 | Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a | ||
| NCT04344600 | Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection | ||
| NCT02968641 | A Study of Lonafarnib With or Without Ritonavir in Patients With HDV | ||
| NCT02736149 | Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) | ||
| NCT00916747 | Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria |
